The antimicrobial peptide YD attenuates inflammation via miR-155 targeting CASP12 during liver fibrosis.
Yan Z, Wang D, An C, Xu H, Zhao Q, Shi Y, Song N, Deng B, Guo X, Rao J, Cheng L, Zhang B, Mou L, Yang W, Jiang X, Xie J.
Yan Z, et al. Among authors: zhao q.
Acta Pharm Sin B. 2021 Jan;11(1):100-111. doi: 10.1016/j.apsb.2020.07.004. Epub 2020 Jul 12.
Acta Pharm Sin B. 2021.
PMID: 33532183
Free PMC article.